Evaluating the impact of novel inhibitors of nuclear pore export in SLE

Ended Project Grant Awarded Last action

Award ID
R43AI124949
Recipient
Awarding agency
Obligated
$225,000

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
Newton, MA 02459, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Original award $225,000

Quick answers

Who received award R43AI124949?

R43AI124949 was awarded to Karyopharm Therapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on April 1, 2016.

How much is award R43AI124949 worth?

$225,000 has been obligated on R43AI124949.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award